CareLit · DOI-Nachweis · Pneumologie
Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing FVC at baseline: the SENSCIS Trial*
DOI 10.1055/s-0039-3403185
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Prasse, TM Maher, O Distler, A Azuma, KB Highland, M Kuwana, MD Mayes, D Wachtlin, M Alves, M Gahlemann, S Stowasser, G Raghu
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74
Kernaussage aus der Literatur
Abstract-Vorschau
Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing FVC at baseline: the SENSCIS Trial*
Zitieren
Zitierempfehlung
A Prasse, TM Maher, O Distler, A Azuma, KB Highland, M Kuwana, MD Mayes, D Wachtlin, M Alves, M Gahlemann, S Stowasser, G Raghu (2020) Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing FVC at baseline: the SENSCIS Trial*. Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403185
Mit CareLit weiterarbeiten